Ziprasidone
- Humans1
- In silico1
Latest
2 in 12 monthsFigshare
GHS-CVRAI: A Receptor-Resolved Cardiovascular Risk Amplification Index for Antipsychotic Prescribing Across Psychiatric Disorders
Preprint: computational studyBiomarkers
Journal of the American Heart Association
Association of Selected Antipsychotic Agents With Major Adverse Cardiovascular Events and Noncardiovascular Mortality in Elderly Persons
Cohort study of 91,774 peoplePopulations